Abbott (ABT) Director Credited 246 Stock Units at $133.94
Patricia Paola Gonzalez, a director of Abbott Laboratories (ABT), had a non-derivative transaction on 09/30/2025 that credited 246 stock equivalent units at an indicated per-share reference of $133.94.
Rhea-AI Filing Summary
Patricia Paola Gonzalez, a director of Abbott Laboratories (ABT), had a non-derivative transaction on 09/30/2025 that credited 246 stock equivalent units at an indicated per-share reference of $133.94. After the reported transaction, the filing shows she beneficially owned 4,922 shares/stock-equivalent units. The filing explains these credits represent director fees placed into a stock equivalent unit account under a director grantor trust, which are paid in cash generally at age 65 or upon retirement from the board and earn the same return as if invested in Abbott shares. The reported Form 4 was signed via attorney-in-fact on 10/02/2025.
Positive
- Director compensation is tied to stock-equivalent units, aligning pay with shareholder returns
- Dividend reinvestment feature is active, as balance includes units from dividends
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Equivalent Units | 246 | $133.94 | $33K |
Footnotes (2)
- F1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
- F2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
FAQ
What transaction did Abbott director Patricia Gonzalez report on Form 4 (ABT)?
How are the stock equivalent units for the director paid or settled?
Does the reported balance include dividend reinvestment?
When was the Form 4 signed and who signed it?
AI-generated analysis. How Rhea-AI works. Not financial advice.